Roland A. L. M. Stallaert

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial

Harm van Tinteren, Otto S. Hoekstra, Egbert F. Smit et al. · The Lancet · 2002 · 864 citations

Medicine, Nuclear Medicine, Oncology +14

Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study

Paul Verboom, Harm van Tinteren, Otto S. Hoekstra et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 138 citations

Medicine, Oncology, Pharmacoeconomics +11

Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.

Anne‐Marie C. Dingemans, M.A. Witlox, Roland A. L. M. Stallaert et al. · PubMed · 1999 · 109 citations

Medicine, Oncology, Pharmacology +15

A Study on the Clinical Equivalence and Patient Preference of Fluticasone Propionate 250 μg Twice Daily via the Diskus^TM/Accuhaler^TMInhaler or the Diskhaler^TM* Inhaler in Adult Asthmatic Patients

Willem R. Pieters, Roland A. L. M. Stallaert, Jan M. Prins et al. · Journal of Asthma · 1998 · 24 citations

Pharmacy, Pharmacology, Pharmacotherapy +17